Comments

Jasper Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Jasper Therapeutics (JSPR) operate in?

Jasper Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

JSPRNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$2.80

-0.04-1.41%

At close: -

$2.80

0.000.00%

After Hours: 7:51 PM EDT

Jasper Therapeutics (JSPR) Forecast

News Earnings Jasper Therapeutics (JSPR) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Jasper Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:JSPR | Benzinga

Explore Jasper Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for JSPR.

Open	$2.84
Close	$2.80
Volume / Avg.	95.01K / 637.07K
Day Range	$2.78 - $2.86
52 Wk Range	2.27 - 26.05
Market Cap	$45.51M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	7.63%
Days to Cover	4.31

Recent News

Jasper Therapeutics Shares Fall On Briquilimab Drug Lot Problem

Jasper shares drop after updated BEACON study shows strong results but faces disruption from compromised drug product lot and halted pipeline programs.

Vandana Singh

Dow Dips 1%; Mustang Bio Shares Spike Higher

Avi Kapoor

Nasdaq Falls Over 100 Points; Capgemini To Acquire WNS

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

May

Jul

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.84
Close	$2.80
Volume / Avg.	95.01K / 637.07K
Day Range	$2.78 - $2.86
52 Wk Range	2.27 - 26.05
Market Cap	$45.51M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	7.63%
Days to Cover	4.31

About Jasper Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures throug...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Jasper Therapeutics (JSPR) stock?

You can purchase shares of Jasper Therapeutics (NASDAQ:JSPR) through any online brokerage.

View our list of the best stock brokerages

Who are Jasper Therapeutics (JSPR) competitors?

Other companies in Jasper Therapeutics’s space includes: Lunai Bioworks (NASDAQ:RENB), Serina Therapeutics (AMEX:SER), Outlook Therapeutics (NASDAQ:OTLK), FibroGen (NASDAQ:FGEN) and Barinthus Biotherapeutics (NASDAQ:BRNS).

What is the forecast, or price target, for Jasper Therapeutics (JSPR) stock?

Jasper Therapeutics has a consensus price target of $29.30.

What is the current price for Jasper Therapeutics (JSPR)?

The stock price for Jasper Therapeutics (NASDAQ: JSPR) is $2.8 last updated August 29, 2025 at 7:51 PM EDT.

Does Jasper Therapeutics (JSPR) pay a dividend?

There are no upcoming dividends for Jasper Therapeutics.

When is Jasper Therapeutics (NASDAQ:JSPR) reporting earnings?

Jasper Therapeutics’s Q3 earnings are confirmed for Thursday, November 6, 2025.

Is Jasper Therapeutics (JSPR) going to split?

There is no upcoming split for Jasper Therapeutics.

What sector and industry does Jasper Therapeutics (JSPR) operate in?

Jasper Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.